BELLUS Health Inc. - Common Shares (NQ:BLU)

N/A UNCHANGED

Last Price Updated: 4:00 PM EDT, Jun 28, 2023 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about BELLUS Health Inc. - Common Shares

< Previous 1 2 3 4 Next >

36 Stocks Moving In Tuesday's Mid-Day Session ↗

September 14, 2021

Gainers FuelCell Energy, Inc. (NASDAQ: FCEL) shares jumped 26% to $7.08 after the company reported better-than-expected Q3 results. BELLUS Health Inc. (NASDAQ: BLU) shares...

Via Benzinga

Mid-Morning Market Update: Markets Mostly Lower; US Annual Inflation Rate Slows to 5.3% in August ↗

September 14, 2021

Following the market opening Tuesday, the Dow traded down 0.26% to 34,778.27 while the NASDAQ rose 0.01% to 15,106.84. The S&P also fell, dropping 0.20% to 4,459.89. The U.S....

Via Benzinga

Topics Stocks

What's Going On With BELLUS Health's Stock Today? ↗

September 13, 2021

BELLUS Health Inc (NASDAQ: BLU) is trading higher Monday after the company announced interim analysis from the Phase 2b SOOTHE trial of BLU-5937 in refractory chronic cough....

Via Benzinga

Understanding BELLUS Health's Unusual Options Activity ↗

August 12, 2021

On Thursday, shares of BELLUS Health (NASDAQ:BLU) saw unus...

Via Benzinga

The Daily Biotech Pulse: NRx Rises On COVID-19 Drug Collaboration, Amgen's Lung Cancer Drug Conditionally Approved In Canada, Coherus Data Readout ↗

September 14, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 13) Abbott Laboratories (NYSE...

Via Benzinga

BELLUS Health Stock Shines After Refractory Chronic Cough Trial Data ↗

September 13, 2021

BELLUS Health Inc (NASDAQ: BLU) has announced a positive interim analysis from Phase 2b SOOTHE trial of BLU-5937 for refractory chronic cough (RCC). BLU-5937, the...

Via Benzinga

BELLUS Health Announces Positive Interim Analysis from the Phase 2b SOOTHE Trial of BLU-5937 in Refractory Chronic Cough

September 13, 2021

From BELLUS Health Inc.

Via Business Wire

72 Biggest Movers From Yesterday ↗

September 14, 2021

Gainers aTyr Pharma, Inc. (NASDAQ: LIFE) jumped 67% to settle at $9.15 on Monday as the company announced positive results from its Phase 1b/2a trial evaluating its lead...

Via Benzinga

BELLUS Health to Present at the H.C. Wainwright Global Investment Conference

September 02, 2021

From BELLUS Health Inc.

Via Business Wire

BELLUS Health to Report Additional RELIEF Data in an Oral Presentation at the European Respiratory Society International Congress 2021

August 23, 2021

From BELLUS Health Inc.

Via Business Wire

BELLUS Health Reports Second Quarter 2021 Financial Results and Business Highlights

August 11, 2021

From BELLUS Health Inc.

Via Business Wire

BELLUS Health Inc. (NASDAQ:BLU) Long Term Shareholder Notice: Investigation of Potential Wrongdoing ↗

July 01, 2021

San Diego, CA -- (SBWIRE) -- 07/01/2021 -- Certain directors of BELLUS Health Inc are under investigation concerning potential breaches of fiduciary duties.

Via SBWire

Topics Lawsuit

BELLUS Health to Participate in the Jefferies Virtual Healthcare Conference

May 25, 2021

From BELLUS Health Inc.

Via Business Wire

BELLUS Health Inc. (NASDAQ:BLU) Investor Notice: Deadline in Lawsuit on May 17, 2021 ↗

May 17, 2021

San Diego, CA -- (SBWIRE) -- 05/17/2021 -- A deadline is coming up on May 17, 2021 in the lawsuit filed for certain investors of BELLUS Health Inc. (NASDAQ:BLU).

Via SBWire

Topics Lawsuit

DEADLINE TODAY: The Schall Law Firm Reminds Investors of Class Action Lawsuit Against BELLUS Health Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

May 17, 2021

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

BLU FINAL DEADLINE ALERT: ROSEN, GLOBALLY RECOGNIZED INVESTOR COUNSEL, Encourages BELLUS Health Inc. Investors to Secure Counsel Before Important Monday Deadline in Securities Class Action – BLU

May 15, 2021

From The Rosen Law Firm, P.A.

Via Business Wire

BLU CLASS ACTION FILING DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff in a Securities Class Action Lawsuit Against BELLUS Health, Inc.

May 15, 2021

NEW YORK, NY / ACCESSWIRE / May 15, 2021 / Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class...

From Bernstein Liebhard LLP

Via AccessWire

Topics Lawsuit

DEADLINE MONDAY ALERT: The Schall Law Firm Reminds Investors of Class Action Lawsuit Against BELLUS Health Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

May 14, 2021

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Bellus Health, Inc. and Encourages Investors to Contact the Firm

May 13, 2021

From Bragar Eagel & Squire, P.C.

Via Business Wire

The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against BELLUS Health Inc. (BLU)

May 13, 2021

From The Law Offices of Frank R. Cruz

Via Business Wire

MONDAY DEADLINE NOTICE: The Schall Law Firm Reminds Investors of Class Action Lawsuit Against BELLUS Health Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

May 13, 2021

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

MONDAY DEADLINE REMINDER: The Schall Law Firm Reminds Investors of Class Action Lawsuit Against BELLUS Health Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

May 12, 2021

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

BELLUS Health to Participate in the 2021 RBC Capital Markets Global Healthcare Conference

May 12, 2021

From BELLUS Health Inc.

Via Business Wire

MONDAY DEADLINE ALERT: The Schall Law Firm Reminds Investors of Class Action Lawsuit Against BELLUS Health Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

May 11, 2021

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

BELLUS Health Reports First Quarter 2021 Financial Results and Business Highlights

May 10, 2021

From BELLUS Health Inc.

Via Business Wire

7-DAY DEADLINE ALERT: The Schall Law Firm Reminds Investors of Class Action Lawsuit Against BELLUS Health Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

May 10, 2021

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

BELLUS Health to Present at the American Thoracic Society 2021 International Conference

May 10, 2021

From BELLUS Health Inc.

Via Business Wire

BLU CLASS ACTION FILING DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff in a Securities Class Action Lawsuit Against BELLUS Health, Inc.

April 29, 2021

NEW YORK, NY / ACCESSWIRE / April 29, 2021 / Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class...

From Bernstein Liebhard LLP

Via AccessWire

Topics Lawsuit

BLU Upcoming Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds BELLUS Health Inc. Investors of Class Action and Lead Plaintiff Deadline: May 17, 2021

April 28, 2021

From Bronstein, Gewirtz & Grossman, LLC

Via Business Wire

BLU Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies BELLUS Health Inc. Investors of Class Action and Encourages Shareholders to Contact the Firm

April 13, 2021

From Bronstein, Gewirtz & Grossman, LLC

Via Business Wire

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.